Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Coulter And Venture Capital Firm Form Company To Develop B1 Antibody For NHL
This article is from
The Cancer Letter
archive.
Vol. 21 No. 17 | April 28, 1995
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
FDA Deputy Commissioner Gottlieb To Return To AEI.
December 15, 2006
TCL Archive
MOPP Consequences, Including Increase In cure Rate, Describe By DeVita
May 25, 1979
TCL Archive
DeVita Reshuffling NCI Office Space
April 18, 1980
TCL Archive
NCI-Approved Clinical Trials Listed For April 2001
May 25, 2001
TCL Archive
Alan Rabson Named NCI Deputy Director
August 11, 1995
TCL Archive
Breast Cancer Action Claims “Victory On Avastin.”
December 14, 2007